Drug Trial Radar · NCT04460885
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
Last checked: Nov 20, 2026Latest source record: Dec 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
984
Actual
Start
Nov 25, 2020
Primary completion
May 29, 2022
Study completion Dec 1, 2022
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jul 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compares insulin icodec (a new insulin taken once a week) to insulin glargine (an insulin taken once daily which is already available on the market) in people with type 2 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. Participants will either get insulin icodec that participants will have to inject once a week on the same day of the week or insulin glargine that participants will have to inject once a day at the same time every day. Which treatment participants get is decided by chance. The insulin is injected with a needle in a skin fold in the thigh, upper arm or stomach. The study will last for about 1 ½ years. Participants will have 37 clinic visits and 26 phone calls with the study doctor. At 11 clinic visits participant will have blood samples taken. At 8 clinic visits participants cannot eat or drink (except for water) for 8 hours before the visit. Participants will be asked to wear a sensor that measures the blood sugar all the time in 5 periods of about one month during the study (about 5 months in total). Women cannot take part if pregnant, breast-feeding or plan to become pregnant during the study period.
Conditions
- Diabetes Mellitus, Type 2
Interventions
Insulin icodecDrug
Participants will receive subcutaneous (s.c.) injections of insulin icodec once weekly for 78 weeks.
Insulin glargineDrug
Participants will receive subcutaneous (s.c.) injections of insulin glargine once daily for 78 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Glycated Haemoglobin (HbA1c)Time frame: Baseline (week 0), Week 52
Locations
198 sites in 13 countries. Site status is shown where the registry gives one.
Uni of Alabama at Birmingham
Birmingham, Alabama
Lakeview Clinical Research, LLC
Guntersville, Alabama
Lynn Institute of the Ozarks
Little Rock, Arkansas
Anaheim Clinical Trials
Anaheim, California
Advanced Clinical Research/Rancho Paseo Medical Group
Banning, California
American Clinical Trials
Buena Park, California
San Fernando Valley Hlth Inst, LLC
Canoga Park, California
Med Center Medical Clinic
Carmichael, California
Headlands Research California, LLC
Escondido, California
Valley Research
Fresno, California
Scripps Whittier Diabetes Inst
La Jolla, California
First Valley Medical Group
Lancaster, California
Clinical Trials Research_Sacramento
Lincoln, California
Torrance Clin Res Inst, Inc.
Lomita, California
Providence Clinical Research
North Hollywood, California
Valley Clinical Trials, Inc.
Northridge, California
Desert Oasis Hlthcr Med Group
Palm Springs, California
NorCal Endocrinology and Internal Medicine_Roseville
Roseville, California
Diabetes Research Center
Tustin, California
Coastal Metabolic Research Center
Ventura, California
Denver Endocrinology Diabetes and Thyroid Center
Englewood, Colorado
Chase Medical Research LLC
Waterbury, Connecticut
Revival Research
Doral, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
Jacksonville Ctr For Clin Res
Jacksonville, Florida
University Of Miami
Miami, Florida
Suncoast Clin Res Port Richey
New Port Richey, Florida
Florida Inst For Clin Res
Orlando, Florida
Palm Harbor Medical Associates
Palm Harbor, Florida
Suncoast Clinical Research, Inc.
Palm Harbor, Florida
Metabolic Research Institute Inc
West Palm Beach, Florida
Clinical Research of Cent FL
Winter Haven, Florida
Atlanta VA Medical Center
Decatur, Georgia
Physicians Research Assoc. LLC
Lawrenceville, Georgia
RNA America Health Sciences
Sugar Hill, Georgia
East West Medical Research Institute_Honolulu
Honolulu, Hawaii
Elite Clinical Trials
Blackfoot, Idaho
Cedar-Crosse Research Center
Chicago, Illinois
Clinical Invest Special_Gurnee
Gurnee, Illinois
Central Illinois Diabetes and Clinical Research
Springfield, Illinois
Showing 40 of 198 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.